79276-23-6

Basic information

• Product Name: D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid
• Synonyms: D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid;D-Threonine, O-(1,1-diMethylethyl)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-;O-(1,1-Dimethylethyl)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-D-threonine;(2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)butanoic acid
• CAS NO: 79276-23-6
• Molecular Formula: C15H25N3O6
• Molecular Weight: 343.3755
• EINECS: 1806241-263-5
• Mol File: 79276-23-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid(CAS DataBase Reference)
• NIST Chemistry Reference: D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid(79276-23-6)
• EPA Substance Registry System: D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid(79276-23-6)

Safety Data

• Hazardous Substances Data: 79276-23-6(Hazardous Substances Data)

Usage

General Description

D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid, also known as voglibose, is a medication used to treat type 2 diabetes. It belongs to the class of drugs called alpha-glucosidase inhibitors, which work by slowing down the digestion of carbohydrates in the body. This helps to lower blood sugar levels after meals and reduce the risk of spikes in glucose levels. Voglibose is typically taken before meals to help control blood sugar levels and is often used in combination with other diabetes medications. It is available in tablet form and is generally well-tolerated, with common side effects including bloating, gas, and diarrhea. Overall, voglibose is an important tool in the management of type 2 diabetes and can help individuals better control their blood sugar levels.